Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1 -Mutated AML - the SAL/AMLCG Vincent Trial

Blood (2024) 144 (Supplement 1): 1527.1.

https://doi.org/10.1182/blood-2024-198164

Published: 2024

Journal Articles

Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms

Blood (2023) 141 (23): 2824–2840.

https://doi.org/10.1182/blood.2022015653

Published: 2023

Includes: Supplemental data

Journal Articles

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Blood (2020) 136 (6): 698–714.

https://doi.org/10.1182/blood.2019003062

Published: 2020

Includes: Supplemental data

Journal Articles

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

Blood (2019) 134 (Supplement_1): 3741.

https://doi.org/10.1182/blood-2019-125973

Published: 2019

Journal Articles

BCR-Induced VLA-4 Activation in the TCL1 Transgenic Mouse Model for Chronic Lymphocytic Leukemia

Eva Szenes, Andrea Härzschel, Erika Tissino, PhD, Pischeli Justine, Julia Gutjahr, Sandra Pennisi, Jan Höpner, Alexander Egle, MD, Nadja Zaborsky, Marie Follo, Sarah Decker, PhD, Christine Dierks, Alexandre Chigaev, Antonella Zucchetto, Valter Gattei, MD, Richard Greil, MD, Tanja Nicole Hartmann, PhD

Blood (2019) 134 (Supplement_1): 1730.

https://doi.org/10.1182/blood-2019-125634

Published: 2019

Journal Articles

The Pan-PIM Kinase Inhibitor LGB321 Strongly Increases Ibrutinib Effects in CLL, By Blocking Anti-Apoptotic Pathways and Microenvironmental Interactions

Sarah Decker, PhD, Shifa Saleem, Sandra Kissel, Anabel Zwick, Konrad Aumann, Katja Zirlik, MD, Justus Duyster, Prof., Christine Dierks

Blood (2018) 132 (Supplement 1): 1840.

https://doi.org/10.1182/blood-2018-99-114424

Published: 2018

Journal Articles

The Pan-PIM Kinase Inhibitor LGB321 Affects Apoptotic Pathways and Microenvironmental Interactions in CLL

Sarah Decker, PhD, Sandra Kissel, Konrad Aumann, MD, Thorsten Zenz, Katja Zirlik, MD, Rainer Claus, MD, Justus Duyster, MD, Christine Dierks, MD

Blood (2016) 128 (22): 4370.

https://doi.org/10.1182/blood.V128.22.4370.4370

Published: 2016

Journal Articles

PIM1 Inhibition Enhances and Prolongs Plerixafor-Induced Mobilization of HSCs

Tony Andreas Müller, PhD, Anabel Zwick, Sarah Decker, PhD, Claudius Klein, PhD, Benjamin Rister, MD, Alina Rudorf, Sandra Kissel, Marie Follo, PhD, Ralph Wäsch, MD, Anna Lena Illert, MD, Claudia Waskow, PhD, Christine Dierks, MD, Justus Duyster, MD

Blood (2016) 128 (22): 655.

https://doi.org/10.1182/blood.V128.22.655.655

Published: 2016

Journal Articles

NIPA As a Novel Regulator of Aging and Stress Response of the Primitive HSC Pool

Stefanie Kreutmair, Rouzanna Istvanffy, PhD, Cathrin Klingeberg, PhD, Christine Dierks, MD, Christian Peschel, MD, Robert A.J. Oostendorp, BSc, MSc, PhD, Justus Duyster, MD PhD, Anna Lena Illert, MD

Blood (2015) 126 (23): 1155.

https://doi.org/10.1182/blood.V126.23.1155.1155

Published: 2015

Journal Articles

Depletion of Ptch2 Activates Canonical and Non-Canonical HH Signaling within the Niche Leading to Myeloproliferation, Stem Cell Exhaustion and Accelerates JAK2V617F Driven Disease

Claudius Klein, Anabel Kuhn, Sandra Kissel, Marie Follo, PhD, Anna Lena Illert, MD, Dietmar Pfeifer, Heike L Pahl, PhD, Robert A.J. Oostendorp, PhD, Justus Duyster, MD, Christine Dierks, MD

Blood (2015) 126 (23): 3593.

https://doi.org/10.1182/blood.V126.23.3593.3593

Published: 2015

Journal Articles

Preclinical Analysis of Linsitinib for the Treatment of Polycythemia Vera

Titiksha Basu, Albert Gruender, PhD, Christine Dierks, MD, Heike L Pahl, PhD

Blood (2015) 126 (23): 2825.

https://doi.org/10.1182/blood.V126.23.2825.2825

Published: 2015

Journal Articles

SYK Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia

Marco Benkisser-Petersen, Maike Buchner, Arlette Dörffel, Marcus Dühren von Minden, Kerstin Leberecht, Kathrin Kläsener, Rainer Claus, MD, Ariane Ott, Christine Dierks, Hassan Jumaa, Fabio Malavasi, Michael Reth, Hendrik Veelken, Katja Zirlik, MD

Blood (2015) 126 (23): 2910.

https://doi.org/10.1182/blood.V126.23.2910.2910

Published: 2015

Journal Articles

Combination Of Kinase Inhibitors Overcomes B-Raf Inhibitor-Induced Paradoxical ERK Activation In CLL Cells In Vitro – Potential Implications For CLL Treatment

Niuscha Yaktapour, Christine Dierks, Dietmar Pfeifer, Hassan Jumaa, Hendrik Veelken, MD PhD, Tilman Brummer, Katja Zirlik

Blood (2013) 122 (21): 4121.

https://doi.org/10.1182/blood.V122.21.4121.4121

Published: 2013

Journal Articles

Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia

Niuscha Yaktapour, Rudolf Übelhart, Julia Schüler, Konrad Aumann, Christine Dierks, Meike Burger, Dietmar Pfeifer, Hassan Jumaa, Hendrik Veelken, Tilman Brummer, Katja Zirlik

Blood (2013) 122 (9): 1621–1633.

https://doi.org/10.1182/blood-2013-02-484386

Published: 2013

Includes: Supplemental data

Journal Articles

Comparison of the Transforming Effect of Different SYK Oncogenes in Vivo Reveals TEL-SYK As Inducer of an MDS/MPS Overlap Syndrome in Mice

Clara Sprissler, Helga Maurer, Hassan Jumaa, PhD, Hendrik Veelken, MD PhD, Christine Dierks

Blood (2012) 120 (21): 1310.

https://doi.org/10.1182/blood.V120.21.1310.1310

Published: 2012

Journal Articles

IGF1R Inhibition Induces Apoptosis in Chronic Lymphocytic Leukemia

Niuscha Yaktapour, Rudolf Uebelhart, Christine Dierks, Meike Burger, Dietmar Pfeifer, Hassan Jumaa, Hendrik Veelken, MD PhD, Tilman Brummer, Katja Zirlik

Blood (2012) 120 (21): 3864.

https://doi.org/10.1182/blood.V120.21.3864.3864

Published: 2012

Journal Articles

PIM Kinase Inhibitors Interfere with the Protective CLL Microenvironment by Blocking CXCR4 Surface Expression and Function

Sarah Decker, Johannes Finter, Katja Zirlik, Hendrik Veelken, MD PhD, Christine Dierks

Blood (2012) 120 (21): 3867.

https://doi.org/10.1182/blood.V120.21.3867.3867

Published: 2012

Journal Articles

Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL

Sarah Decker, Katja Zirlik, Lauritte Djebatchie, David Hartmann, Gabriele Ihorst, Annette Schmitt-Graeff, Dieter Herchenbach, Hassan Jumaa, Markus Warmuth, Hendrik Veelken, Christine Dierks

Blood (2012) 119 (4): 997–1007.

https://doi.org/10.1182/blood-2011-06-359075

Published: 2012

Includes: Supplemental data

Journal Articles

SYK Inhibition Targets CD38−Mediated Survival and Proliferation Signals in Chronic Lymphocytic Leukemia Cells

Maike Buchner, PhD, Natalie Stickel, MS, Arlette Dörffel, BS, Ariane Ott, BS, Marcus Duehren von Minden, MS, Christine Dierks, MD, Hassan Jumaa, PhD, Hendrik J. Veelken, MD, PhD, Katja Zirlik, MD

Blood (2011) 118 (21): 800.

https://doi.org/10.1182/blood.V118.21.800.800

Published: 2011

Journal Articles

Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia

Maike Buchner, Constance Baer, Gabriele Prinz, Christine Dierks, Meike Burger, Thorsten Zenz, Stephan Stilgenbauer, Hassan Jumaa, Hendrik Veelken, Katja Zirlik

Blood (2010) 115 (22): 4497–4506.

https://doi.org/10.1182/blood-2009-07-233692

Published: 2010

Includes: Supplemental data

NARROW

Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1 -Mutated AML - the SAL/AMLCG Vincent Trial

Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

BCR-Induced VLA-4 Activation in the TCL1 Transgenic Mouse Model for Chronic Lymphocytic Leukemia

The Pan-PIM Kinase Inhibitor LGB321 Strongly Increases Ibrutinib Effects in CLL, By Blocking Anti-Apoptotic Pathways and Microenvironmental Interactions

The Pan-PIM Kinase Inhibitor LGB321 Affects Apoptotic Pathways and Microenvironmental Interactions in CLL

PIM1 Inhibition Enhances and Prolongs Plerixafor-Induced Mobilization of HSCs

NIPA As a Novel Regulator of Aging and Stress Response of the Primitive HSC Pool

Depletion of Ptch2 Activates Canonical and Non-Canonical HH Signaling within the Niche Leading to Myeloproliferation, Stem Cell Exhaustion and Accelerates JAK2V617F Driven Disease

Preclinical Analysis of Linsitinib for the Treatment of Polycythemia Vera

SYK Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia

Combination Of Kinase Inhibitors Overcomes B-Raf Inhibitor-Induced Paradoxical ERK Activation In CLL Cells In Vitro – Potential Implications For CLL Treatment

Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia

Comparison of the Transforming Effect of Different SYK Oncogenes in Vivo Reveals TEL-SYK As Inducer of an MDS/MPS Overlap Syndrome in Mice

IGF1R Inhibition Induces Apoptosis in Chronic Lymphocytic Leukemia

PIM Kinase Inhibitors Interfere with the Protective CLL Microenvironment by Blocking CXCR4 Surface Expression and Function

Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL

SYK Inhibition Targets CD38−Mediated Survival and Proliferation Signals in Chronic Lymphocytic Leukemia Cells

Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only